Investing
Shanghai Exchange urges bankers to vet Chinese medical firms IPOs – sources
© Reuters. FILE PHOTO: A men wearing a mask walk at the Shanghai Stock Exchange building at the Pudong financial district in Shanghai, China, as the country is hit by an outbreak of a new coronavirus, February 3, 2020. REUTERS/Aly Song/File Photo
SHANGHAI (Reuters) – The Shanghai Stock Exchange has urged bankers to pay close attention to the marketing practices of Chinese drug and medical equipment makers seeking initial public offerings (IPOs) amid an escalating anti-corruption drive in the sector, sources said.
The bourse asked investment bankers and lawyers to ensure drugmakers’ compliance and legitimacy in sales and marketing activities, according to an internal publication the exchange sent to bankers in late July that was reviewed by Reuters.
Two banking sources familiar with the issue confirmed the information. The Shanghai exchange declined to comment.
Read the full article here
-
Investing5 days ago
This All-Access Pass to Learning Is Now $20 for Black Friday
-
Passive Income5 days ago
How to Create a Routine That Balances Rest and Business Success
-
Side Hustles6 days ago
Apple Prepares a New AI-Powered Siri to Compete With ChatGPT
-
Side Hustles3 days ago
A Macy’s Employee Made Accounting Errors Worth $132 Million
-
Investing2 days ago
Factbox-How Trump can overhaul US financial regulators when he takes office By Reuters
-
Passive Income6 days ago
Customers Want More Than Just a Product — Here’s How to Keep Up
-
Side Hustles5 days ago
Gift the Power of Language Learning with This Limited-Time Price on Babbel
-
Investing3 days ago
Palantir assigned Street-high targets by Wedbush and BofA By Investing.com